BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35032258)

  • 21. Down-regulation of miRNA-196b expression inhibits the proliferation, migration and invasiveness of HepG2 cells while promoting their apoptosis via the PI3K/Akt signaling pathway.
    Xu F; Zhu F; Wang W; Gao W; Chen X; Yu C
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):159-164. PubMed ID: 32538764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4.
    Zhu MX; Wei CY; Zhang PF; Gao DM; Chen J; Zhao Y; Dong SS; Liu BB
    J Exp Clin Cancer Res; 2019 Sep; 38(1):409. PubMed ID: 31533816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid hormone receptor interactor 13 (TRIP13) overexpression associated with tumor progression and poor prognosis in lung adenocarcinoma.
    Li W; Zhang G; Li X; Wang X; Li Q; Hong L; Shen Y; Zhao C; Gong X; Chen Y; Zhou J
    Biochem Biophys Res Commun; 2018 May; 499(3):416-424. PubMed ID: 29567476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F; Tian L; Zhou Q; Feng D
    Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRIP13 promotes lung cancer cell growth and metastasis through AKT/mTORC1/c-Myc signaling.
    Cai W; Ni W; Jin Y; Li Y
    Cancer Biomark; 2021; 30(2):237-248. PubMed ID: 33136091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
    Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
    Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
    Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
    Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis.
    Zhang G; Zhu Q; Fu G; Hou J; Hu X; Cao J; Peng W; Wang X; Chen F; Cui H
    Br J Cancer; 2019 Dec; 121(12):1069-1078. PubMed ID: 31740732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gamabufotalin suppressed osteosarcoma stem cells through the TGF-β/periostin/PI3K/AKT pathway.
    Ma K; Zhang C; Li W
    Chem Biol Interact; 2020 Nov; 331():109275. PubMed ID: 33010222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y; Cheng H; Li W; Wu H; Yang Y
    Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PENK inhibits osteosarcoma cell migration by activating the PI3K/Akt signaling pathway.
    Zhang HP; Yu ZL; Wu BB; Sun FR
    J Orthop Surg Res; 2020 Apr; 15(1):162. PubMed ID: 32334633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-939-5p directly targets IGF-1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K/Akt pathway.
    Zhao X; Li J; Yu D
    Int J Mol Med; 2019 Nov; 44(5):1833-1843. PubMed ID: 31545400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway.
    Li B; Yang Y; Jiang S; Ni B; Chen K; Jiang L
    Int J Oncol; 2012 Nov; 41(5):1809-19. PubMed ID: 22948234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
    Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J
    Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SPAG5 promotes the proliferation, migration, invasion, and epithelial-mesenchymal transformation of colorectal cancer cells by activating the PI3K/AKT signaling pathway.
    Zhang X; Wu W; Li X; He F; Zhang L
    Chin J Physiol; 2023; 66(5):365-371. PubMed ID: 37929348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C₁₈H₁₇NO₆ Inhibits Invasion and Migration of Human MNNG Osteosarcoma Cells via the PI3K/AKT Signaling Pathway.
    Qu Q; He Z; Jiang Y; Lu D; Long X; Ding Y; Xu B; He X
    Med Sci Monit; 2019 Oct; 25():7527-7537. PubMed ID: 31589596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway.
    Liu M; Zhang J; Dong H; Wang W
    J Cell Physiol; 2019 Nov; 234(11):20879-20887. PubMed ID: 31001861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alantolactone suppresses human osteosarcoma through the PI3K/AKT signaling pathway.
    Zhang Y; Weng Q; Han J; Chen J
    Mol Med Rep; 2020 Feb; 21(2):675-684. PubMed ID: 31974628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEGF Silencing Inhibits Human Osteosarcoma Angiogenesis and Promotes Cell Apoptosis via PI3K/AKT Signaling Pathway.
    Zhao J; Zhang ZR; Zhao N; Ma BA; Fan QY
    Cell Biochem Biophys; 2015 Nov; 73(2):519-525. PubMed ID: 27352347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
    Li YJ; Dong BK; Fan M; Jiang WX
    Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.